Papers
9
Total Citations
1,057
H-Index
7
About
Edward Uchio is a leading urologic oncologist whose research centers on advancing surgical treatments for bladder and prostate cancers, as well as benign prostatic hyperplasia (BPH). He is best known as the principal investigator of the landmark RAZOR trial, a phase 3 randomized study demonstrating that robot-assisted radical cystectomy is non-inferior to open surgery for bladder cancer, with 2-year progression-free survival outcomes that have reshaped clinical practice. This seminal work has garnered over 760 citations. Dr. Uchio has also pioneered the use of Aquablation therapy for large prostates (80–150 cc), leading the WATER II trial through 5-year follow-up and establishing a minimally invasive option with durable symptom relief. His contributions extend to comparative effectiveness research in robotic versus open prostatectomy for locally advanced disease, and he has authored influential reviews on improving urinary continence after radical prostatectomy. With a career marked by high-impact clinical trials and a focus on patient-centered outcomes, Dr. Uchio’s work has directly informed surgical decision-making and improved quality of life for men with urologic conditions.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9